The Experience of Implementing a National Antimicrobial Resistance Surveillance System in Brazil

Pillonetto, Marcelo; Jordão, Regiane Tigulini de Souza; Andraus, Gabriel Savogin; Bergamo, Ricardo; Rocha, Fabiano Barreto; Onishi, Mayara Caroline; Almeida, Bernardo Montesanti Machado de; Nogueira, Keite da Silva; Lin, Amanda Dal; Dias, Viviane Maria de Carvalho Hessel; Abreu, André Luiz de

doi:10.3389/fpubh.2020.575536

Cited by 29 publications

(28 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In Nepal, Malla et al [ 14 ] had, by 2014, already highlighted the challenges to AMR surveillance implementation, giving high importance to data collection, compilation, and storage. Many others later noted that the availability of an electronic data collection system with data back-up, as opposed to manual paperwork collection, would result in a smoother workflow and better data flow from the surveillance sites to a central reporting site [ 15 , 16 , 17 , 18 ]. The use of WHONET software, with its uniform and standardized format, would facilitate an easy compilation for GLASS reporting [ 19 ].…”

Section: Discussionmentioning

confidence: 99%

Quality Assessment of an Antimicrobial Resistance Surveillance System in a Province of Nepal

et al. 2021

View full text Add to dashboard Cite

Antimicrobial resistance (AMR) is a global problem, and Nepal is no exception. Countries are expected to report annually to the World Health Organization on their AMR surveillance progress through a Global Antimicrobial Resistance Surveillance System, in which Nepal enrolled in 2017. We assessed the quality of AMR surveillance data during 2019–2020 at nine surveillance sites in Province 3 of Nepal for completeness, consistency, and timeliness and examined barriers for non-reporting sites. Here, we present the results of this cross-sectional descriptive study of secondary AMR data from five reporting sites and barriers identified through a structured questionnaire completed by representatives at the five reporting and four non-reporting sites. Among the 1584 records from the reporting sites assessed for consistency and completeness, 77–92% were consistent and 88–100% were complete, with inter-site variation. Data from two sites were received by the 15th day of the following month, whereas receipt was delayed by a mean of 175 days at three other sites. All four non-reporting sites lacked dedicated data personnel, and two lacked computers. The AMR surveillance data collection process needs improvement in completeness, consistency, and timeliness. Non-reporting sites need support to meet the specific requirements for data compilation and sharing.

show abstract

Section: Discussionmentioning

confidence: 99%

Quality Assessment of an Antimicrobial Resistance Surveillance System in a Province of Nepal

et al. 2021

View full text Add to dashboard Cite

show abstract

“…12 23–25 One study included the analysis of 2 EIS, 26 resulting in a total of 27 EIS overall included in this systematic scoping review from 26 studies and reports. Of the 27 EIS, the country of implementation was specified for 21: Uganda, 27 India, 28 Portugal, 29 Italy, 23 Australia, 30–32 Netherlands, 33 Germany, 34 Brazil, 35 UK, 36 USA, 24 37 38 Argentina, 25 Taiwan, 39 France, 26 Russia, 40 Switzerland 41 and Denmark. 42 Three EIS described utilisation across multiple countries, 12 43 44 and three EIS are not specific to a location.…”

Section: Resultsmentioning

confidence: 99%

Electronic information systems for One Health surveillance of antimicrobial resistance: a systematic scoping review

Oberin

Badger

Faverjon³

et al. 2022

BMJ Glob Health

View full text Add to dashboard Cite

IntroductionElectronic information systems (EIS) that implement a ‘One Health’ approach by integrating antimicrobial resistance (AMR) data across the human, animal and environmental health sectors, have been identified as a global priority. However, evidence on the availability, technical capacities and effectiveness of such EIS is scarce.MethodsThrough a qualitative synthesis of evidence, this systematic scoping review aims to: identify EIS for AMR surveillance that operate across human, animal and environmental health sectors; describe their technical characteristics and capabilities; and assess whether there is evidence for the effectiveness of the various EIS for AMR surveillance. Studies and reports between 1 January 2000 and 21 July 2021 from peer-reviewed and grey literature in the English language were included.Results26 studies and reports were included in the final review, of which 27 EIS were described. None of the EIS integrated AMR data in a One Health approach across all three sectors. While there was a lack of evidence of thorough evaluations of the effectiveness of the identified EIS, several surveillance system effectiveness indicators were reported for most EIS. Standardised reporting of the effectiveness of EIS is recommended for future publications. The capabilities of the EIS varied in their technical design features, in terms of usability, data display tools and desired outputs. EIS that included interactive features, and geospatial maps are increasingly relevant for future trends in AMR data analytics.ConclusionNo EIS for AMR surveillance was identified that was designed to integrate a broad range of AMR data from humans, animals and the environment, representing a major gap in global efforts to implement One Health approaches to address AMR.

show abstract

“…A long-term surveillance programme exists in Brazil, led by the National Health Regulatory Agency (ANVISA), but it compiles data from healthcare-associated infections and a gap remains about overall AMR, especially considering the WHO One Health initiative where not only resistant nosocomial bacteria are monitored but also bacteria from the community. 12 Between 2016 and 2017, national discussions took place to prepare the Brazilian NAP and an important objective included joining the Global Antimicrobial Resistance and Use Surveillance System (GLASS) and to significantly expand the scope, which resulted in 2017 in Brazil joining GLASS and starting its National Surveillance Program on Antimicrobial Resistance (BR-GLASS). 12 …”

Section: Surveillancementioning

confidence: 99%

“… 12 Between 2016 and 2017, national discussions took place to prepare the Brazilian NAP and an important objective included joining the Global Antimicrobial Resistance and Use Surveillance System (GLASS) and to significantly expand the scope, which resulted in 2017 in Brazil joining GLASS and starting its National Surveillance Program on Antimicrobial Resistance (BR-GLASS). 12 …”

Section: Surveillancementioning

confidence: 99%

Country data on AMR in Brazil in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome

Torumkuney

Nijhara

Beltrame

et al. 2022

Journal of Antimicrobial Chemotherapy

View full text Add to dashboard Cite

Background Antimicrobial resistance (AMR) is one of the biggest threats to global public health. Selection of resistant bacteria is driven by inappropriate use of antibiotics, amongst other factors. COVID-19 may have exacerbated AMR due to unnecessary antibiotic prescribing. Country-level knowledge is needed to understand options for action. Objectives To review the situation with respect to AMR in Brazil and initiatives addressing it. Identifying areas where more information is required will provide a call to action to minimize any further rises in AMR within Brazil and to improve patient outcomes. Methods National initiatives to address AMR, antibiotic use and prescribing in Brazil, and availability of susceptibility data, particularly for the key community-acquired respiratory tract infections (CA-RTI) pathogens Streptococcus pneumoniae and Haemophilus influenzae, were identified. National and international antibiotic prescribing guidelines for CA-RTIs (community-acquired pneumonia, acute otitis media and acute bacterial rhinosinusitis) commonly used locally were also reviewed, along with local antibiotic availability. Conclusions In Brazil there have been some initiatives addressing AMR such as the National Action Plan for AMR, established in 2018. Antibiotic consumption in Brazil is high but a ban on over-the-counter sales of antibiotics has led to a decrease in consumption. Local antibiotic susceptibility testing needs to be increased and the Survey of Antibiotic Resistance (SOAR) study in Brazil will provide useful data for pathogens causing CA-RTIs. A more standardized inclusive approach in developing local guidelines, using up-to-date surveillance data of isolates from community-acquired infections in Brazil, could make guideline use more locally relevant for clinicians. This would pave the way for a higher level of appropriate antibiotic prescribing and improved adherence. This would, in turn, potentially limit AMR development and improve clinical outcomes for patients.

show abstract

The Experience of Implementing a National Antimicrobial Resistance Surveillance System in Brazil

Cited by 29 publications

References 44 publications

Quality Assessment of an Antimicrobial Resistance Surveillance System in a Province of Nepal

Quality Assessment of an Antimicrobial Resistance Surveillance System in a Province of Nepal

Electronic information systems for One Health surveillance of antimicrobial resistance: a systematic scoping review

Country data on AMR in Brazil in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome

Contact Info

Product

Resources

About